AstraZeneca to seek approval for blood pressure drug by year-end

Astrazeneca News Headlines. AZN Share News. Financial News Articles for Astrazeneca Plc Ord Shs $0.25 updated throughout the day.

Astrazeneca News Headlines. AZN Share News. Financial News Articles for Astrazeneca Plc Ord Shs $0.25 updated throughout the day.

AstraZeneca is said to seek approval for antihypertensive this year

Astra Pill Cuts Hard-to-Treat Blood Pressure in Late-Stage Trial

AstraZeneca Plc said its experimental hypertension pill reduced blood pressure by more than twice as much as standard treatment in a large late-stage study, bolstering its chances of competing in a crowded field.

AstraZeneca to seek approval for blood pressure drug by year-end

AstraZeneca plans to file for regulatory approval of its experimental blood pressure treatment before the end of the year, a senior company executive said, about a product seen as key to the...

AstraZeneca aims for 2025 filing with what it calls 'best-in-class' hypertension pill, but will likely face competition

MADRID — Pivotal data on AstraZeneca’s blood pressure pill baxdrostat look good enough for approval, but competing in the market might be a harder ask as the company prepares for a potential match against another new ...

Headline Unavailable